A 12 week, Phase 2A, Randomized, Subject and Investigato

Project: Research project

Description

A 12 week, Phase 2A, Randomized, Subject and Investigator Blinded, Placebo-Controlled Trial to Evaluate the Safety, Tolerability and Efficacy of CE-326,597
StatusFinished
Effective start/end date2/26/0812/31/08

Funding

  • PFIZER, INC.

Fingerprint

Placebos
Research Personnel
Safety